These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 6188905)
41. Effect of mexiletine, amiodarone and disopyramide on the excitability and refractoriness of canine cardiac fibers: possible relation to antiarrhythmic drug action and classification. Nakaya Y; Elharrar V; Surawicz B Cardiovasc Drugs Ther; 1987 Aug; 1(2):141-53. PubMed ID: 3154317 [TBL] [Abstract][Full Text] [Related]
42. Effects of disopyramide and mexiletine on the terminal repolarization process of the in situ heart assessed using the halothane-anesthetized in vivo canine model. Yoshida H; Sugiyama A; Satoh Y; Ishida Y; Kugiyama K; Hashimoto K Circ J; 2002 Sep; 66(9):857-62. PubMed ID: 12224826 [TBL] [Abstract][Full Text] [Related]
43. Electrophysiological effects of the combination of mexiletine and flecainide in guinea-pig ventricular fibres. Delpón E; Valenzuela C; Tamargo J Br J Pharmacol; 1991 Jun; 103(2):1411-6. PubMed ID: 1909200 [TBL] [Abstract][Full Text] [Related]
44. Electrophysiologic interactions between mexiletine-quinidine and mexiletine-ropitoin in guinea pig papillary muscle. Valenzuela C; Sanchez-Chapula J J Cardiovasc Pharmacol; 1989 Nov; 14(5):783-9. PubMed ID: 2481194 [TBL] [Abstract][Full Text] [Related]
45. Interaction between selected sodium and potassium channel blockers in guinea pig papillary muscle. Wang L; Chiamvimonvat N; Duff HJ J Pharmacol Exp Ther; 1993 Mar; 264(3):1056-62. PubMed ID: 8383735 [TBL] [Abstract][Full Text] [Related]
46. Slow kinetic property of mexiletine in guinea pig atrium. Shirayama T; Inoue D; Inoue M; Miyazaki H; Tatsumi T; Asayama J; Katsume H; Nakagawa M Pharmacol Toxicol; 1992 Mar; 70(3):168-72. PubMed ID: 1579541 [TBL] [Abstract][Full Text] [Related]
47. Two types of sodium channel block by class-I antiarrhythmic drugs studied by using Vmax of action potential in single ventricular myocytes. Kodama I; Honjo H; Kamiya K; Toyama J J Mol Cell Cardiol; 1990 Jan; 22(1):1-12. PubMed ID: 2157851 [TBL] [Abstract][Full Text] [Related]
48. Effects of mexiletine on steady-state characteristics and recovery kinetics of V max and conduction velocity in guinea pig myocardium. Hohnloser S; Weirich J; Antoni H J Cardiovasc Pharmacol; 1982; 4(2):232-9. PubMed ID: 6175806 [TBL] [Abstract][Full Text] [Related]
49. Electrophysiologic effects of encainide on acutely ischemic rabbit myocardial cells. Wong SS; Myerburg RJ; Ezrin AM; Gelband H; Bassett AL Eur J Pharmacol; 1982 Jun; 80(4):323-9. PubMed ID: 6809479 [TBL] [Abstract][Full Text] [Related]
51. Assessment of drug effects on spontaneous and induced ventricular arrhythmias in a 24-h canine infarction model. Gomoll AW Arzneimittelforschung; 1987 Jul; 37(7):787-94. PubMed ID: 3118889 [TBL] [Abstract][Full Text] [Related]
52. Electrophysiologic effects of an antiarrhythmic agent, bidisomide, on sodium current in isolated rat ventricular myocytes: comparison with mexiletine and disopyramide. Homma N; Tsujimoto G; Hashimoto K Jpn J Pharmacol; 2001 May; 86(1):23-31. PubMed ID: 11430469 [TBL] [Abstract][Full Text] [Related]
53. Prolongation of the QT interval by dofetilide modulates rate-dependent effects of mexiletine on intraventricular conduction. Todt H; Zojer N; Raberger G; Schütz W Eur J Pharmacol; 1994 Nov; 265(1-2):43-52. PubMed ID: 7883028 [TBL] [Abstract][Full Text] [Related]
54. The antifibrillatory potency of aprindine, mexiletine, tocainide and lignocaine compared on Langendorff-perfused hearts of rabbits and guinea-pigs. Almotrefi AA; Baker JB J Pharm Pharmacol; 1980 Nov; 32(11):746-50. PubMed ID: 6110721 [TBL] [Abstract][Full Text] [Related]
55. Selective depression of conduction of premature action potentials in canine Purkinje fibres by class Ib antiarrhythmic drugs: comparison with Ia and Ic drugs. Pallandi RT; Campbell TJ Cardiovasc Res; 1988 Mar; 22(3):171-8. PubMed ID: 3167941 [TBL] [Abstract][Full Text] [Related]
56. Effects of CM7857, a derivative of disopyramide, on electrophysiologic properties of canine Purkinje fibers and inotropic properties of canine ventricular muscle. Endou K; Yamamoto H; Sato T; Nakata F J Cardiovasc Pharmacol; 1986; 8(3):507-13. PubMed ID: 2425165 [TBL] [Abstract][Full Text] [Related]
57. Electrophysiological effects of AN-132, a new antiarrhythmic compound, in guinea pig papillary muscles. Imanishi S; Morita S; Arita M J Cardiovasc Pharmacol; 1990 Mar; 15(3):476-84. PubMed ID: 1691373 [TBL] [Abstract][Full Text] [Related]
58. In-vitro and in-vivo electrophysiologic effects of encainide. Libersa C; Caron J; Rouet R Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():567-72. PubMed ID: 2125834 [TBL] [Abstract][Full Text] [Related]
59. Electrocardiographic interactions between pinacidil, a potassium channel opener and class I antiarrhythmic agents in guinea-pig isolated perfused heart. Yang Q; Padrini R; Bova S; Piovan D; Magnolfi G Br J Pharmacol; 1995 Apr; 114(8):1745-9. PubMed ID: 7599944 [TBL] [Abstract][Full Text] [Related]
60. Electrophysiological effects of 711389-S, a new antiarrhythmic agent, on guinea-pig isolated cardiac muscle. Ninomiya M; Toyama J; Kodama I; Yamada K J Cardiovasc Pharmacol; 1984; 6(6):1222-9. PubMed ID: 6084783 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]